Site recruitment
advanced/metastatic RCC, RCC
RECRUITMENT, RCC
REFINE is open to NHS hospitals throughout the United Kingdom (UK). Site recruitment has been organised in ‘waves’ of hospitals, grouped by their accrual to RAMPART (a phase III trial platform trial of adjuvant therapy in high/intermediate risk RCC) and PRISM (a randomised phase II trial of nivolumab with alternatively scheduled ipilimu-mab in advanced/metastatic RCC) [